Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.

Children with Down syndrome (DS) up to the age of 4 years are at a 150-fold excess risk of developing myeloid leukemia (ML-DS). Approximately 4%-5% of newborns with DS develop transient myeloproliferative disorder (TMD). Blast cell structure and immunophenotype are similar in TMD and ML-DS. A mutati...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Alford, K, Reinhardt, K, Garnett, C, Norton, A, Böhmer, K, von Neuhoff, C, Kolenova, A, Marchi, E, Klusmann, J, Roberts, I, Hasle, H, Reinhardt, D, Vyas, P
বিন্যাস: Journal article
ভাষা:English
প্রকাশিত: 2011